Pembrolizumab for Previously Treated Advanced or Metastatic Urothelial Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

Overview of attention for article published in PharmacoEconomics, July 2018

Altmetric Badge

Mentioned by

So far, Altmetric has seen 1 public wall post.

#HealthEconJA Pembrolizumab for Previously Treated Advanced or Metastatic Urothelial Cancer: An Evidence Review Group…

This page shows the most recent Facebook posts that mention this research output.

Click here to find out how to access more activity.